Mutation Station: Transgenomic's WAVE System Eliminates Base-by-Base Search

A minor alteration in a single gene of the human body can be a major contributor to the development of a wide spectrum of diseases ranging from cystic fibrosis to cancer. With the Human Genome Project in full swing, the number of genes available to analyze for these changes is growing daily. The increased demand for genetic testing also requires rapid screening capabilities. Transgenomic Inc. recognized this need and has designed an automated high-throughput system for mutation detection. Trans

Written byAmy Francis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A minor alteration in a single gene of the human body can be a major contributor to the development of a wide spectrum of diseases ranging from cystic fibrosis to cancer. With the Human Genome Project in full swing, the number of genes available to analyze for these changes is growing daily. The increased demand for genetic testing also requires rapid screening capabilities. Transgenomic Inc. recognized this need and has designed an automated high-throughput system for mutation detection. Transgenomic's WAVE Nucleic Acid Fragment Analysis System eliminates the need to search base by base for a single alteration by detecting mutations in regions of DNA as large as 1.5 kilobases at one time.

Transgenomic's temperature modulated heteroduplex analysis system The WAVE System couples the efficiency of heteroduplex analysis (HA) with the convenience of chromatography in a highly automated system that makes mutation detection faster than blind sequencing or gel-based HA methods. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies